Global Universal Nuclease Market Growth 2025-2031--LP INFORMATION, INC.

Global Universal Nuclease Market Growth 2025-2031

Product Code: 1538919

Industry: Medical Devices & Consumables

Published: May 13,2025

Pages: 101

Delivery Time: 2-3 business days

Global Universal Nuclease Market Growth 2025-2031

Product Code: 1538919

Industry: Medical Devices & Consumables

Published: May 13,2025

Pages: 101

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Universal Nuclease market size is predicted to grow from US$ 390 million in 2025 to US$ 647 million in 2031; it is expected to grow at a CAGR of 8.8% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Universal nuclease, a genetically engineered enzyme from Serratia Marcescen. It can degrade all forms of DNA and RNA, including single-stranded, double-stranded, linear, circular, native and denatured nucleic acids, digesting them into 5-monophosphate oligonucleotides of 3-8 bases in length, and has no base recognition specificity.

United States market for Universal Nuclease is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Universal Nuclease is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Universal Nuclease is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Universal Nuclease players cover Thermo Fisher Scientific Inc., RayBiotech, Inc., TransGen Biotech, AbMole BioScience, Yisheng Biotechnology (Shanghai) Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Universal Nuclease Industry Forecast” looks at past sales and reviews total world Universal Nuclease sales in 2024, providing a comprehensive analysis by region and market sector of projected Universal Nuclease sales for 2025 through 2031. With Universal Nuclease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Universal Nuclease industry.

This Insight Report provides a comprehensive analysis of the global Universal Nuclease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Universal Nuclease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Universal Nuclease market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Universal Nuclease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Universal Nuclease.

This report presents a comprehensive overview, market shares, and growth opportunities of Universal Nuclease market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

5kU

    25kU

    50kU

    100kU

    ＞100kU

Segmentation by Application:

    Biological Laboratory

    University Research Room

    Others

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Thermo Fisher Scientific Inc.

    RayBiotech, Inc.

    TransGen Biotech

    AbMole BioScience

    Yisheng Biotechnology (Shanghai) Co., Ltd.

    GenScript

    Shanghai Biyuntian Biotechnology Co., Ltd.

    KACTUS

    Shanghai Zhudian Biotechnology Co., Ltd.

    ACROBiosystems Group

Key Questions Addressed in this Report

What is the 10-year outlook for the global Universal Nuclease market?

What factors are driving Universal Nuclease market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Universal Nuclease market opportunities vary by end market size?

How does Universal Nuclease break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Universal Nuclease Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Universal Nuclease by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Universal Nuclease by Country/Region, 2020, 2024 & 2031
    2.2 Universal Nuclease Segment by Type
        2.2.1 5kU
        2.2.2 25kU
        2.2.3 50kU
        2.2.4 100kU
        2.2.5 ＞100kU
    2.3 Universal Nuclease Sales by Type
        2.3.1 Global Universal Nuclease Sales Market Share by Type (2020-2025)
        2.3.2 Global Universal Nuclease Revenue and Market Share by Type (2020-2025)
        2.3.3 Global Universal Nuclease Sale Price by Type (2020-2025)
    2.4 Universal Nuclease Segment by Application
        2.4.1 Biological Laboratory
        2.4.2 University Research Room
        2.4.3 Others
    2.5 Universal Nuclease Sales by Application
        2.5.1 Global Universal Nuclease Sale Market Share by Application (2020-2025)
        2.5.2 Global Universal Nuclease Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Universal Nuclease Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Universal Nuclease Breakdown Data by Company
        3.1.1 Global Universal Nuclease Annual Sales by Company (2020-2025)
        3.1.2 Global Universal Nuclease Sales Market Share by Company (2020-2025)
    3.2 Global Universal Nuclease Annual Revenue by Company (2020-2025)
        3.2.1 Global Universal Nuclease Revenue by Company (2020-2025)
        3.2.2 Global Universal Nuclease Revenue Market Share by Company (2020-2025)
    3.3 Global Universal Nuclease Sale Price by Company
    3.4 Key Manufacturers Universal Nuclease Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Universal Nuclease Product Location Distribution
        3.4.2 Players Universal Nuclease Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Universal Nuclease by Geographic Region
    4.1 World Historic Universal Nuclease Market Size by Geographic Region (2020-2025)
        4.1.1 Global Universal Nuclease Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Universal Nuclease Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Universal Nuclease Market Size by Country/Region (2020-2025)
        4.2.1 Global Universal Nuclease Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Universal Nuclease Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Universal Nuclease Sales Growth
    4.4 APAC Universal Nuclease Sales Growth
    4.5 Europe Universal Nuclease Sales Growth
    4.6 Middle East & Africa Universal Nuclease Sales Growth

5 Americas
    5.1 Americas Universal Nuclease Sales by Country
        5.1.1 Americas Universal Nuclease Sales by Country (2020-2025)
        5.1.2 Americas Universal Nuclease Revenue by Country (2020-2025)
    5.2 Americas Universal Nuclease Sales by Type (2020-2025)
    5.3 Americas Universal Nuclease Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Universal Nuclease Sales by Region
        6.1.1 APAC Universal Nuclease Sales by Region (2020-2025)
        6.1.2 APAC Universal Nuclease Revenue by Region (2020-2025)
    6.2 APAC Universal Nuclease Sales by Type (2020-2025)
    6.3 APAC Universal Nuclease Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Universal Nuclease by Country
        7.1.1 Europe Universal Nuclease Sales by Country (2020-2025)
        7.1.2 Europe Universal Nuclease Revenue by Country (2020-2025)
    7.2 Europe Universal Nuclease Sales by Type (2020-2025)
    7.3 Europe Universal Nuclease Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Universal Nuclease by Country
        8.1.1 Middle East & Africa Universal Nuclease Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Universal Nuclease Revenue by Country (2020-2025)
    8.2 Middle East & Africa Universal Nuclease Sales by Type (2020-2025)
    8.3 Middle East & Africa Universal Nuclease Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Universal Nuclease
    10.3 Manufacturing Process Analysis of Universal Nuclease
    10.4 Industry Chain Structure of Universal Nuclease

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Universal Nuclease Distributors
    11.3 Universal Nuclease Customer

12 World Forecast Review for Universal Nuclease by Geographic Region
    12.1 Global Universal Nuclease Market Size Forecast by Region
        12.1.1 Global Universal Nuclease Forecast by Region (2026-2031)
        12.1.2 Global Universal Nuclease Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Universal Nuclease Forecast by Type (2026-2031)
    12.7 Global Universal Nuclease Forecast by Application (2026-2031)

13 Key Players Analysis
13.1 Thermo Fisher Scientific Inc.
13.1.1 Thermo Fisher Scientific Inc. Company Information
13.1.2 Thermo Fisher Scientific Inc. Universal Nuclease Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific Inc. Universal Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Thermo Fisher Scientific Inc. Main Business Overview
13.1.5 Thermo Fisher Scientific Inc. Latest Developments
13.2 RayBiotech, Inc.
13.2.1 RayBiotech, Inc. Company Information
13.2.2 RayBiotech, Inc. Universal Nuclease Product Portfolios and Specifications
13.2.3 RayBiotech, Inc. Universal Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 RayBiotech, Inc. Main Business Overview
13.2.5 RayBiotech, Inc. Latest Developments
13.3 TransGen Biotech
13.3.1 TransGen Biotech Company Information
13.3.2 TransGen Biotech Universal Nuclease Product Portfolios and Specifications
13.3.3 TransGen Biotech Universal Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 TransGen Biotech Main Business Overview
13.3.5 TransGen Biotech Latest Developments
13.4 AbMole BioScience
13.4.1 AbMole BioScience Company Information
13.4.2 AbMole BioScience Universal Nuclease Product Portfolios and Specifications
13.4.3 AbMole BioScience Universal Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AbMole BioScience Main Business Overview
13.4.5 AbMole BioScience Latest Developments
13.5 Yisheng Biotechnology (Shanghai) Co., Ltd.
13.5.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
13.5.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Universal Nuclease Product Portfolios and Specifications
13.5.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Universal Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Main Business Overview
13.5.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Latest Developments
13.6 GenScript
13.6.1 GenScript Company Information
13.6.2 GenScript Universal Nuclease Product Portfolios and Specifications
13.6.3 GenScript Universal Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 GenScript Main Business Overview
13.6.5 GenScript Latest Developments
13.7 Shanghai Biyuntian Biotechnology Co., Ltd.
13.7.1 Shanghai Biyuntian Biotechnology Co., Ltd. Company Information
13.7.2 Shanghai Biyuntian Biotechnology Co., Ltd. Universal Nuclease Product Portfolios and Specifications
13.7.3 Shanghai Biyuntian Biotechnology Co., Ltd. Universal Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Shanghai Biyuntian Biotechnology Co., Ltd. Main Business Overview
13.7.5 Shanghai Biyuntian Biotechnology Co., Ltd. Latest Developments
13.8 KACTUS
13.8.1 KACTUS Company Information
13.8.2 KACTUS Universal Nuclease Product Portfolios and Specifications
13.8.3 KACTUS Universal Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 KACTUS Main Business Overview
13.8.5 KACTUS Latest Developments
13.9 Shanghai Zhudian Biotechnology Co., Ltd.
13.9.1 Shanghai Zhudian Biotechnology Co., Ltd. Company Information
13.9.2 Shanghai Zhudian Biotechnology Co., Ltd. Universal Nuclease Product Portfolios and Specifications
13.9.3 Shanghai Zhudian Biotechnology Co., Ltd. Universal Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Shanghai Zhudian Biotechnology Co., Ltd. Main Business Overview
13.9.5 Shanghai Zhudian Biotechnology Co., Ltd. Latest Developments
13.10 ACROBiosystems Group
13.10.1 ACROBiosystems Group Company Information
13.10.2 ACROBiosystems Group Universal Nuclease Product Portfolios and Specifications
13.10.3 ACROBiosystems Group Universal Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 ACROBiosystems Group Main Business Overview
13.10.5 ACROBiosystems Group Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Universal Nuclease Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Universal Nuclease Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of 5kU
 Table 4. Major Players of 25kU
 Table 5. Major Players of 50kU
 Table 6. Major Players of 100kU
 Table 7. Major Players of ＞100kU
 Table 8. Global Universal Nuclease Sales by Type (2020-2025) & (K Units)
 Table 9. Global Universal Nuclease Sales Market Share by Type (2020-2025)
 Table 10. Global Universal Nuclease Revenue by Type (2020-2025) & ($ million)
 Table 11. Global Universal Nuclease Revenue Market Share by Type (2020-2025)
 Table 12. Global Universal Nuclease Sale Price by Type (2020-2025) & (US$/Unit)
 Table 13. Global Universal Nuclease Sale by Application (2020-2025) & (K Units)
 Table 14. Global Universal Nuclease Sale Market Share by Application (2020-2025)
 Table 15. Global Universal Nuclease Revenue by Application (2020-2025) & ($ million)
 Table 16. Global Universal Nuclease Revenue Market Share by Application (2020-2025)
 Table 17. Global Universal Nuclease Sale Price by Application (2020-2025) & (US$/Unit)
 Table 18. Global Universal Nuclease Sales by Company (2020-2025) & (K Units)
 Table 19. Global Universal Nuclease Sales Market Share by Company (2020-2025)
 Table 20. Global Universal Nuclease Revenue by Company (2020-2025) & ($ millions)
 Table 21. Global Universal Nuclease Revenue Market Share by Company (2020-2025)
 Table 22. Global Universal Nuclease Sale Price by Company (2020-2025) & (US$/Unit)
 Table 23. Key Manufacturers Universal Nuclease Producing Area Distribution and Sales Area
 Table 24. Players Universal Nuclease Products Offered
 Table 25. Universal Nuclease Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 26. New Products and Potential Entrants
 Table 27. Market M&A Activity & Strategy
 Table 28. Global Universal Nuclease Sales by Geographic Region (2020-2025) & (K Units)
 Table 29. Global Universal Nuclease Sales Market Share Geographic Region (2020-2025)
 Table 30. Global Universal Nuclease Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 31. Global Universal Nuclease Revenue Market Share by Geographic Region (2020-2025)
 Table 32. Global Universal Nuclease Sales by Country/Region (2020-2025) & (K Units)
 Table 33. Global Universal Nuclease Sales Market Share by Country/Region (2020-2025)
 Table 34. Global Universal Nuclease Revenue by Country/Region (2020-2025) & ($ millions)
 Table 35. Global Universal Nuclease Revenue Market Share by Country/Region (2020-2025)
 Table 36. Americas Universal Nuclease Sales by Country (2020-2025) & (K Units)
 Table 37. Americas Universal Nuclease Sales Market Share by Country (2020-2025)
 Table 38. Americas Universal Nuclease Revenue by Country (2020-2025) & ($ millions)
 Table 39. Americas Universal Nuclease Sales by Type (2020-2025) & (K Units)
 Table 40. Americas Universal Nuclease Sales by Application (2020-2025) & (K Units)
 Table 41. APAC Universal Nuclease Sales by Region (2020-2025) & (K Units)
 Table 42. APAC Universal Nuclease Sales Market Share by Region (2020-2025)
 Table 43. APAC Universal Nuclease Revenue by Region (2020-2025) & ($ millions)
 Table 44. APAC Universal Nuclease Sales by Type (2020-2025) & (K Units)
 Table 45. APAC Universal Nuclease Sales by Application (2020-2025) & (K Units)
 Table 46. Europe Universal Nuclease Sales by Country (2020-2025) & (K Units)
 Table 47. Europe Universal Nuclease Revenue by Country (2020-2025) & ($ millions)
 Table 48. Europe Universal Nuclease Sales by Type (2020-2025) & (K Units)
 Table 49. Europe Universal Nuclease Sales by Application (2020-2025) & (K Units)
 Table 50. Middle East & Africa Universal Nuclease Sales by Country (2020-2025) & (K Units)
 Table 51. Middle East & Africa Universal Nuclease Revenue Market Share by Country (2020-2025)
 Table 52. Middle East & Africa Universal Nuclease Sales by Type (2020-2025) & (K Units)
 Table 53. Middle East & Africa Universal Nuclease Sales by Application (2020-2025) & (K Units)
 Table 54. Key Market Drivers & Growth Opportunities of Universal Nuclease
 Table 55. Key Market Challenges & Risks of Universal Nuclease
 Table 56. Key Industry Trends of Universal Nuclease
 Table 57. Universal Nuclease Raw Material
 Table 58. Key Suppliers of Raw Materials
 Table 59. Universal Nuclease Distributors List
 Table 60. Universal Nuclease Customer List
 Table 61. Global Universal Nuclease Sales Forecast by Region (2026-2031) & (K Units)
 Table 62. Global Universal Nuclease Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 63. Americas Universal Nuclease Sales Forecast by Country (2026-2031) & (K Units)
 Table 64. Americas Universal Nuclease Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 65. APAC Universal Nuclease Sales Forecast by Region (2026-2031) & (K Units)
 Table 66. APAC Universal Nuclease Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 67. Europe Universal Nuclease Sales Forecast by Country (2026-2031) & (K Units)
 Table 68. Europe Universal Nuclease Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 69. Middle East & Africa Universal Nuclease Sales Forecast by Country (2026-2031) & (K Units)
 Table 70. Middle East & Africa Universal Nuclease Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 71. Global Universal Nuclease Sales Forecast by Type (2026-2031) & (K Units)
 Table 72. Global Universal Nuclease Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 73. Global Universal Nuclease Sales Forecast by Application (2026-2031) & (K Units)
 Table 74. Global Universal Nuclease Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 75. Thermo Fisher Scientific Inc. Basic Information, Universal Nuclease Manufacturing Base, Sales Area and Its Competitors
 Table 76. Thermo Fisher Scientific Inc. Universal Nuclease Product Portfolios and Specifications
 Table 77. Thermo Fisher Scientific Inc. Universal Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Thermo Fisher Scientific Inc. Main Business
 Table 79. Thermo Fisher Scientific Inc. Latest Developments
 Table 80. RayBiotech, Inc. Basic Information, Universal Nuclease Manufacturing Base, Sales Area and Its Competitors
 Table 81. RayBiotech, Inc. Universal Nuclease Product Portfolios and Specifications
 Table 82. RayBiotech, Inc. Universal Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. RayBiotech, Inc. Main Business
 Table 84. RayBiotech, Inc. Latest Developments
 Table 85. TransGen Biotech Basic Information, Universal Nuclease Manufacturing Base, Sales Area and Its Competitors
 Table 86. TransGen Biotech Universal Nuclease Product Portfolios and Specifications
 Table 87. TransGen Biotech Universal Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. TransGen Biotech Main Business
 Table 89. TransGen Biotech Latest Developments
 Table 90. AbMole BioScience Basic Information, Universal Nuclease Manufacturing Base, Sales Area and Its Competitors
 Table 91. AbMole BioScience Universal Nuclease Product Portfolios and Specifications
 Table 92. AbMole BioScience Universal Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. AbMole BioScience Main Business
 Table 94. AbMole BioScience Latest Developments
 Table 95. Yisheng Biotechnology (Shanghai) Co., Ltd. Basic Information, Universal Nuclease Manufacturing Base, Sales Area and Its Competitors
 Table 96. Yisheng Biotechnology (Shanghai) Co., Ltd. Universal Nuclease Product Portfolios and Specifications
 Table 97. Yisheng Biotechnology (Shanghai) Co., Ltd. Universal Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Yisheng Biotechnology (Shanghai) Co., Ltd. Main Business
 Table 99. Yisheng Biotechnology (Shanghai) Co., Ltd. Latest Developments
 Table 100. GenScript Basic Information, Universal Nuclease Manufacturing Base, Sales Area and Its Competitors
 Table 101. GenScript Universal Nuclease Product Portfolios and Specifications
 Table 102. GenScript Universal Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. GenScript Main Business
 Table 104. GenScript Latest Developments
 Table 105. Shanghai Biyuntian Biotechnology Co., Ltd. Basic Information, Universal Nuclease Manufacturing Base, Sales Area and Its Competitors
 Table 106. Shanghai Biyuntian Biotechnology Co., Ltd. Universal Nuclease Product Portfolios and Specifications
 Table 107. Shanghai Biyuntian Biotechnology Co., Ltd. Universal Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Shanghai Biyuntian Biotechnology Co., Ltd. Main Business
 Table 109. Shanghai Biyuntian Biotechnology Co., Ltd. Latest Developments
 Table 110. KACTUS Basic Information, Universal Nuclease Manufacturing Base, Sales Area and Its Competitors
 Table 111. KACTUS Universal Nuclease Product Portfolios and Specifications
 Table 112. KACTUS Universal Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. KACTUS Main Business
 Table 114. KACTUS Latest Developments
 Table 115. Shanghai Zhudian Biotechnology Co., Ltd. Basic Information, Universal Nuclease Manufacturing Base, Sales Area and Its Competitors
 Table 116. Shanghai Zhudian Biotechnology Co., Ltd. Universal Nuclease Product Portfolios and Specifications
 Table 117. Shanghai Zhudian Biotechnology Co., Ltd. Universal Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Shanghai Zhudian Biotechnology Co., Ltd. Main Business
 Table 119. Shanghai Zhudian Biotechnology Co., Ltd. Latest Developments
 Table 120. ACROBiosystems Group Basic Information, Universal Nuclease Manufacturing Base, Sales Area and Its Competitors
 Table 121. ACROBiosystems Group Universal Nuclease Product Portfolios and Specifications
 Table 122. ACROBiosystems Group Universal Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. ACROBiosystems Group Main Business
 Table 124. ACROBiosystems Group Latest Developments


List of Figures
 Figure 1. Picture of Universal Nuclease
 Figure 2. Universal Nuclease Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Universal Nuclease Sales Growth Rate 2020-2031 (K Units)
 Figure 7. Global Universal Nuclease Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Universal Nuclease Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Universal Nuclease Sales Market Share by Country/Region (2024)
 Figure 10. Universal Nuclease Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of 5kU
 Figure 12. Product Picture of 25kU
 Figure 13. Product Picture of 50kU
 Figure 14. Product Picture of 100kU
 Figure 15. Product Picture of ＞100kU
 Figure 16. Global Universal Nuclease Sales Market Share by Type in 2025
 Figure 17. Global Universal Nuclease Revenue Market Share by Type (2020-2025)
 Figure 18. Universal Nuclease Consumed in Biological Laboratory
 Figure 19. Global Universal Nuclease Market: Biological Laboratory (2020-2025) & (K Units)
 Figure 20. Universal Nuclease Consumed in University Research Room
 Figure 21. Global Universal Nuclease Market: University Research Room (2020-2025) & (K Units)
 Figure 22. Universal Nuclease Consumed in Others
 Figure 23. Global Universal Nuclease Market: Others (2020-2025) & (K Units)
 Figure 24. Global Universal Nuclease Sale Market Share by Application (2024)
 Figure 25. Global Universal Nuclease Revenue Market Share by Application in 2025
 Figure 26. Universal Nuclease Sales by Company in 2025 (K Units)
 Figure 27. Global Universal Nuclease Sales Market Share by Company in 2025
 Figure 28. Universal Nuclease Revenue by Company in 2025 ($ millions)
 Figure 29. Global Universal Nuclease Revenue Market Share by Company in 2025
 Figure 30. Global Universal Nuclease Sales Market Share by Geographic Region (2020-2025)
 Figure 31. Global Universal Nuclease Revenue Market Share by Geographic Region in 2025
 Figure 32. Americas Universal Nuclease Sales 2020-2025 (K Units)
 Figure 33. Americas Universal Nuclease Revenue 2020-2025 ($ millions)
 Figure 34. APAC Universal Nuclease Sales 2020-2025 (K Units)
 Figure 35. APAC Universal Nuclease Revenue 2020-2025 ($ millions)
 Figure 36. Europe Universal Nuclease Sales 2020-2025 (K Units)
 Figure 37. Europe Universal Nuclease Revenue 2020-2025 ($ millions)
 Figure 38. Middle East & Africa Universal Nuclease Sales 2020-2025 (K Units)
 Figure 39. Middle East & Africa Universal Nuclease Revenue 2020-2025 ($ millions)
 Figure 40. Americas Universal Nuclease Sales Market Share by Country in 2025
 Figure 41. Americas Universal Nuclease Revenue Market Share by Country (2020-2025)
 Figure 42. Americas Universal Nuclease Sales Market Share by Type (2020-2025)
 Figure 43. Americas Universal Nuclease Sales Market Share by Application (2020-2025)
 Figure 44. United States Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 45. Canada Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 46. Mexico Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 47. Brazil Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 48. APAC Universal Nuclease Sales Market Share by Region in 2025
 Figure 49. APAC Universal Nuclease Revenue Market Share by Region (2020-2025)
 Figure 50. APAC Universal Nuclease Sales Market Share by Type (2020-2025)
 Figure 51. APAC Universal Nuclease Sales Market Share by Application (2020-2025)
 Figure 52. China Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 53. Japan Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 54. South Korea Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 55. Southeast Asia Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 56. India Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 57. Australia Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 58. China Taiwan Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 59. Europe Universal Nuclease Sales Market Share by Country in 2025
 Figure 60. Europe Universal Nuclease Revenue Market Share by Country (2020-2025)
 Figure 61. Europe Universal Nuclease Sales Market Share by Type (2020-2025)
 Figure 62. Europe Universal Nuclease Sales Market Share by Application (2020-2025)
 Figure 63. Germany Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 64. France Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 65. UK Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 66. Italy Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 67. Russia Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 68. Middle East & Africa Universal Nuclease Sales Market Share by Country (2020-2025)
 Figure 69. Middle East & Africa Universal Nuclease Sales Market Share by Type (2020-2025)
 Figure 70. Middle East & Africa Universal Nuclease Sales Market Share by Application (2020-2025)
 Figure 71. Egypt Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 72. South Africa Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 73. Israel Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 74. Turkey Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 75. GCC Countries Universal Nuclease Revenue Growth 2020-2025 ($ millions)
 Figure 76. Manufacturing Cost Structure Analysis of Universal Nuclease in 2025
 Figure 77. Manufacturing Process Analysis of Universal Nuclease
 Figure 78. Industry Chain Structure of Universal Nuclease
 Figure 79. Channels of Distribution
 Figure 80. Global Universal Nuclease Sales Market Forecast by Region (2026-2031)
 Figure 81. Global Universal Nuclease Revenue Market Share Forecast by Region (2026-2031)
 Figure 82. Global Universal Nuclease Sales Market Share Forecast by Type (2026-2031)
 Figure 83. Global Universal Nuclease Revenue Market Share Forecast by Type (2026-2031)
 Figure 84. Global Universal Nuclease Sales Market Share Forecast by Application (2026-2031)
 Figure 85. Global Universal Nuclease Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

Thermo Fisher Scientific Inc.

RayBiotech, Inc.

TransGen Biotech

AbMole BioScience

Yisheng Biotechnology (Shanghai) Co., Ltd.

GenScript

Shanghai Biyuntian Biotechnology Co., Ltd.

KACTUS

Shanghai Zhudian Biotechnology Co., Ltd.

ACROBiosystems Group

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff